“The Efficacy of Palivizumab Prophylaxis for Acute Respiratory Syncytial Virus Infections in At-Risk Populations: A Literature Review”. Revista Eletrônica Acervo Médico, vol. 17, Sept. 2022, p. e10854, https://doi.org/10.25248/reamed.e10854.2022.